col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


82 Results       Page 1

 [1] 
Ovid: American Journal of Therapeutics
  original article Date Title Authors   All Authors
1 [GO] 2024―May―01 Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Mortality: A Systematic Literature Review Ashley S. Cha-Silva, Meghan B. Gavaghan, Tobias Bergroth, Ronika Alexander-Parrish, Jingyan Yang, Florin Draica, et al. (+6)
2 [GO] 2024―May―01 Commentary on Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Mortality: A Systematic Literature Review Daniel O. Griffin
3 [GO] 2024―Mar―22 Premature Closure of Scientific Thinking: Deaths Due to Chloroquine and Hydroxychloroquine Used for COVID-19 Infection Peter Manu
4 [GO] 2024―Jan―23 Favipiravir for the Treatment of Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Aiman Naveed, Huzaifa Ahmad Cheema, Abia Shahid, Mohammad Umer, Hassan ul Hussain, Mohammad Ebad Ur Rehman, et al. (+6)
5 [GO] 2024―Jan―16 Clinical Observation of Trimetazidine Combined With Coenzyme Q10 in the Treatment of Myocardial Damage Caused by COVID-19 Xiaochun Ye, Shaohui Zhang
6 [GO] 2024―Jan―16 Myocarditis in Three Japanese Men After the Second mRNA-Based COVID-19 Vaccine Dose Tomiko Sunaga, Michiko Tanaka, Hiromoto Sone, Tatsuya Onuki, Daisuke Wada, Hiroshi Suzuki
7 [GO] 2024―Jan―16 Molnupiravir for the Treatment of Coronavirus Disease 2019: A Systematic Review With Meta-Analysis of 12,451 Patients Azizullah Beran, Asmaa Mhanna, Mohammed Mhanna, David Farrow, Sabeen Sidiki, Yasmin Khader, et al. (+2)
8 [GO] 2023―Sep―15 Fatal Myocarditis After COVID-19 Vaccination: Fourteen Autopsy-Confirmed Cases: Erratum
9 [GO] 2023―Aug―30 Efficacy and Safety of Favipiravir for the Treatment of COVID-19 Outpatients: A Systematic Review and Meta-analysis of Randomized Controlled Trials Huzaifa Ahmad Cheema, Abraish Ali, Mirha Ali, Abia Shahid, Muhammad Saqib Ghafoor, Mohammad Ebad Ur Rehman, et al. (+3)
10 [GO] 2023―May―26 Therapeutic Vaccination Is the Most Promising Intervention for Long COVID Peter Manu
11 [GO] 2023―May―18 Tocilizumab and Corticosteroids Increase Risk of COVID-19-Associated Pulmonary Aspergillosis Development Among Critically Ill Patients Mohammed T. Awad, Rajmund Michal Niwinski, Azizullah Beran, Chad Tidwell, Ayman O. Soubani
12 [GO] 2023―May―18 Therapeutic Messianism: Belladonna for Heroin Withdrawal, Ivermectin for COVID-19 Infection Peter Manu
13 [GO] 2023―May―18 Erythema Multiforme Induced by Zonisamide and Triggered by the First Dose of COVID-19 Vaccine (Pfizer-BioNTech) Tsukasa Murata, Yoshitaka Nobukuni
14 [GO] 2023―May―18 Fatal Myocarditis After COVID-19 Vaccination: Fourteen Autopsy-Confirmed Cases Peter Manu
15 [GO] 2023―Apr―25 Outcome of COVID-19 mRNA Vaccination in Patients Treated With Clozapine WHO Previously Went Through SARS-COV-2 Infection Silvia Moga, Paula Simina Petric, Ana Aliana Miron, Petru Ifteni, Andreea Teodorescu
16 [GO] 2023―Apr―17 Against Authority: The Bioethics of Ivermectin Use for COVID-19 Infection Vasile Astărăstoae, Liliana M. Rogozea
17 [GO] 2023―Mar―07 Rituximab for COVID-19 Vaccine-Associated Pemphigus Vulgaris Hai-Zhen Hui, Ying-Jun Wang, Jia-Rong Cheng, Han Mao, Hong-Xing Guo, Qing-Chun Diao, Bing-Jun Shi
18 [GO] 2023―Mar―01 Antidepressants Are Associated With a Reduction in the Risk of Death in COVID-19 Disease Patients Raquel Cobos-Campos, Arantza Sáez de Lafuente-Moríñigo, José Aurelio Cordero-Guevara, Cristina Bermúdez-Ampudia, Antxon Apiñaniz, Julene Argaluza, Naiara Parraza
19 [GO] 2023―Feb―22 Anakinra-An Interleukin-1 Receptor Antagonist for COVID-19 Timothy Nguyen, Lorena Dima, Kristine C. Willett
20 [GO] 2023―Feb―10 Ivermectin and the Emergence of Long COVID Peter Manu
21 [GO] 2022―Nov―09 Same-Day Deaths After COVID-19 Vaccinations: Autopsy Findings in 54 Cases Peter Manu
22 [GO] 2022―Nov―09 Ivermectin for COVID-19: The 2022 Update Peter Manu
23 [GO] 2022―Nov―09 Aromatherapy and Fermented Fruits for Long COVID: Placebo-Controlled Placebo Trials? Peter Manu
24 [GO] 2022―Aug―19 Remdesivir Administration in COVID-19 Patients With Renal Impairment: A Systematic Review Effat Davoudi-Monfared, Arezoo Ahmadi, Elahe Karimpour-Razkenari, Bita Shahrami, Farhad Najmeddin, Mojtaba Mojtahedzadeh
25 [GO] 2022―Jul―08 Re: Expression of Concern for Bryant A, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection. Am J Ther. 2022;29:e232. Andrew Bryant, Theresa A. Lawrie, Edmund J. Fordham, Scott Mitchell
26 [GO] 2022―Jul―08 Angiotensin II Receptor Blocking Drugs May Increase Severity of Coronavirus Disease 2019 Infection Raquel Cobos-Campos, Cristina Bermúdez-Ampudia, Estibaliz Orruño, Antxon Apiñaniz, Sainza García, Jose Cordero, et al. (+3)
27 [GO] 2022―Jun―24 Neutropenia in Patients With Clozapine-Treated Schizophrenia: An Effect of Clozapine or a Consequence of SARS-CoV-2 Infection? A Systematic Review Silvia Moga, Andreea Teodorescu, Ana Dragan, Ana Aliana Miron, Petru Ifteni
28 [GO] 2022―Jun―20 Plausibility of Claimed Covid-19 Vaccine Efficacies by Age: A Simulation Study Kyle A. Sheldrick, Gideon Meyerowitz-Katz, Greg Tucker-Kellogg
29 [GO] 2022―May―09 Methylprednisolone Versus Dexamethasone in COVID-19: A Meta-Analysis of Nonrandomized Studies Azizullah Beran, Hazem Ayesh, Mohammed Mhanna, Omar Srour, Rami Musallam, Wasef Sayeh, et al. (+5)
30 [GO] 2022―May―09 Methylprednisolone May Be Superior to Dexamethasone in COVID-19: A Meta-Analysis of Randomized Controlled Trials Azizullah Beran, Hazem Ayesh, Mohammed Mhanna, Omar Srour, Rami Musallam, Wasef Sayeh, et al. (+5)
31 [GO] 2022―Apr―27 Use of Anticoagulants in COVID-19: A Review Sam Ngu, John Kolton Smith, Mark Goldin
32 [GO] 2022―Apr―21 The Effect of Colchicine on Mortality, Mechanical Ventilation, and Length of Stay in Patients With COVID-19 Infection: An Updated Systematic Review and Meta-analysis of Randomized Clinical Trials Francisco José Romeo, Leandro Barbagelata, Juan Guido Chiabrando, Juan Ignacio Damonte, Errol Moras, Jose S. Aguilar-Gallardo, et al. (+3)
33 [GO] 2022―Apr―19 Preinfection Anticoagulation/Antiplatelet Therapy Does Not Influence the Outcome of COVID-19 Disease in Hospitalized Patients Jasmeet Kaur, Yaqub N. Mohammed, Amar Lal, Mayuri Kulkarni, Priyanjali Pulipati, Priyadarshini Dixit, et al. (+7)
34 [GO] 2022―Apr―05 Fluvoxamine in Nonhospitalized Patients With Acute COVID-19 Infection and the Lack of Efficacy in Reducing Rates of Hospitalization, Mechanical Ventilation, and Mortality in Placebo-Controlled Trials: A Systematic Review and Meta-Analysis Sapan Bhuta, Waleed Khokher, Nithin Kesireddy, Saffa Iftikhar, Azizullah Beran, Mohammed Mhanna, et al. (+4)
35 [GO] 2022―Apr―05 Fluvoxamine for Acute COVID-19 Infection: Weak Hypothesis, Predictable Failure Peter Manu
36 [GO] 2022―Apr―05 Pneumonitis and Myopericarditis After Booster COVID-19 mRNA Vaccination Ravi B. Singh, Muizz Zaman, Alanna M. Glidden, Sanchari Banerjee, Atika Azhar, Hayas H. Koya, Harvir S. Gambhir
37 [GO] 2022―Apr―05 Dose-Dependent Ivermectin Effect on COVID-19 Polymerase Chain Reaction Status Nirmeen Sabry, Yasser Fouad, Mohamed AbdAllah, Ahmed Cordie, Gamal Esmat
38 [GO] 2022―Apr―05 A Scoping Review of Pharmacological Management of Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2021 Erin Carson, Alice N. Hemenway
39 [GO] 2022―Apr―05 Aortic Mural Thrombosis Diagnosed After a Second Dose of mRNA-1273 SARS-CoV-2 Vaccine Shoheera Punjwani, Prateek Khanna, Chinmay Jani, Joseph Waston, Irmgard Behlau
40 [GO] 2022―Mar―07 Secondary Infection Risk in Patients With Severe COVID-19 Pneumonia Treated With Tocilizumab Gagangeet Sandhu, Samuel T. Piraino, Joshua Piticaru
41 [GO] 2022―Feb―17 Expression of Concern for Bryant a, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection Peter Manu
42 [GO] 2022―Feb―14 Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19 Steven G. Rothrock, Kurt D. Weber, Philip A. Giordano, Mitchell D. Barneck
43 [GO] 2022―Feb―10 Expression of Concern for Kory P, Meduri GU, Varon J, Iglesias J, Marik PE. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am J Ther. 2021;28(3) Peter Manu
44 [GO] 2022―Feb―10 Expression of Concern for Bryant a, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection Peter Manu
45 [GO] 2022―Jan―14 Acute Cardiac Events After ChAdOx1 nCoV-19 Corona Virus Vaccine Rohit Singh, Sankha Shubhra Chakrabarti, Indrajeet Singh Gambhir, Ashish Verma, Ishan Kumar, Soumik Ghosh, et al. (+4)
46 [GO] 2022―Jan―07 Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19 Steven G. Rothrock, Kurt D. Weber, Philip A. Giordano, Mitchell D. Barneck
47 [GO] 2022―Jan―05 Re: “Commentary” by Rothrock et al. “Meta-Analyses Did Not Establish Improved Mortality With Ivermectin Use in COVID-19 Andrew Bryant, Theresa A. Lawrie, Edmund J. Fordham, Scott Mitchell
48 [GO] 2021―Dec―04 Anticoagulation Management and Outcomes in Patients With Covid-19 With Propensity Score Matching Jasmeet Kaur, Jennifer deLongpre, Tracy Koehler, Heather Laclair, Monica Bowen, Justin Khine, et al. (+8)
49 [GO] 2021―Nov―10 Treatment Challenges of ST-Segment Elevation Myocardial Infarction Within the Constraint of COVID-19 Pandemic Hammam Shereef, Ahmed S. Yassin, Ahmed Subahi, Omar Ali
50 [GO] 2021―Nov―10 Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19: Erratum
51 [GO] 2021―Oct―26 Malignant Hyperthermia and Cisatracurium During Severe SARS-CoV-2 Infection Ju-Tae Sohn
52 [GO] 2021―Oct―26 Romiplostim for SARS-CoV-2 Vaccine Induced Immune Thrombocytopenia Ziad Abuhelwa, Ying Ning, Waleed Abdulsattar, Sami Ghazaleh, Navkirat Kahlon, Ahmed Elsayed
53 [GO] 2021―Sep―02 Intensive Treatment With Ivermectin and Iota-Carrageenan as Pre-exposure Prophylaxis for COVID-19 in Health Care Workers From Tucuman, Argentina Rossana E. Chahla, Luis Medina Ruiz, Eugenia S. Ortega, Marcelo F. Morales, Francisco Barreiro, Alexia George, et al. (+5)
54 [GO] 2021―Sep―02 Ivermectin for Prevention and Treatment of COVID-19 Infection Andrew Bryant, Theresa A. Lawrie, Edmund J. Fordham
55 [GO] 2021―Aug―13 Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19 Chia Siang Kow, Syed S. Hasan
56 [GO] 2021―Aug―13 Cisatracurium-Associated Malignant Hyperthermia During Severe Sars-CoV-2 Infection Swaminathan P. Sathyanarayanan, Muhammad Hamza, Khizar Hamid, Dayna Groskreutz
57 [GO] 2021―Jul―29 Effect of Subcutaneous Tocilizumab on Mortality in Patients With COVID-19 Tzu Rong Peng, Ta Wei Wu, An Jan Wu
58 [GO] 2021―Jul―15 Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients Scott J. Morin, Chinmay Jani, Arashdeep Rupal, Harpreet Singh, Daniel Bourque, Robert C. Colgrove
59 [GO] 2021―Jul―05 Increased Mortality in Antecedent Combined Renin-Angiotensin System Inhibitors and Antiplatelets Compared With Antiplatelets Alone in Hospitalized Patients With COVID-19 Yi Lee, Qasim Jehangir, Jasmeet Kaur, Asrar Abdou, Mohammed Ibrahim, Mohamed N. Mandeel, et al. (+6)
60 [GO] 2021―Jun―19 Ivermectin for Prevention and Treatment of COVID-19 Infection Andrew Bryant, Theresa A. Lawrie, Therese Dowswell, Edmund J. Fordham, Scott Mitchell, Sarah R. Hill, Tony C. Tham
61 [GO] 2021―Jun―12 Clinical Features and Lymphocyte Subsets in Recovered COVID-19 Patients With Prolonged Viral RNA Shedding Duration Wei-Yun Zhang, Jia-Jia Wang, Ying-Ying Liu, Da-Xiong Zeng
62 [GO] 2021―Jun―12 Tocilizumab-Associated Cecal Perforation in COVID-19 Pneumonia Josephine Adunse, Nithin Kesireddy, Waleed Khokher, Prabath Herath Mudiyanselage, Hyder Ali, Ragheb Assaly
63 [GO] 2021―Jun―12 Immune Thrombocytopenic Purpura Associated With Pfizer-BioNTech COVID-19 Vaccine Refractory to Conventional Treatment Ghulam Ghous, Allahyar ., Muhammad Usman Zafar, Zahid Ijaz Tarar, Hafiz Muhammad Hassan Shoukat
64 [GO] 2021―Jun―12 Colchicine Treatment in SARS-CoV-2 Infection Azizullah Beran, Mohammed Mhanna, Waseem Wahood, Sami Ghazaleh, Omar Sajdeya, Muhamad Kalifa, et al. (+5)
65 [GO] 2021―Jun―12 A Global Early Empirical Therapy Randomized Study Design for Ivermectin in SARS-CoV-2 Infection Emmanuel Bhaskar
66 [GO] 2021―May―05 Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19 Pierre Kory, Gianfranco Umberto Meduri, Joseph Varon, Jose Iglesias, Paul E. Marik
67 [GO] 2021―May―05 COVID-19 Vaccine-Associated Takotsubo Cardiomyopathy Chinmay Jani, Jeffrey Leavitt, Omar Al Omari, Alana Dimaso, Kyle Pond, Stephen Gannon, et al. (+3)
68 [GO] 2021―Apr―17 Arrhythmias in Patients With Coronavirus Disease 2019 Treated With Hydroxychloroquine and/or Azithromycin Urvashi Hooda, Nicholas Feola, Christopher Nabors, Abhay Dhand
69 [GO] 2021―Mar―09 Digital Health Technology and Telemedicine-Based Hospital and Home Programs in Pulmonary Medicine During the COVID-19 Pandemic Jonathan Ilowite, Gita Lisker, Harly Greenberg
70 [GO] 2021―Jan―13 Heparin-Induced Thrombocytopenia in a Patient With Coronavirus Disease-19 Tariq Kewan, Fahrettin Covut, Hamed Daw, Abdo Haddad
71 [GO] 2021―Jan―13 Effects of Hydroxychloroquine With or Without Azithromycin on QT Interval in COVID-19 Siddharth Shah, Kuldeep Shah, Mohit K. Turagam, Dhanunjaya Lakkireddy, Jalaj Garg
72 [GO] 2021―Jan―04 Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and the Risk of SARS-CoV-2 Infection or Hospitalization With COVID-19 Disease Imad M. Tleyjeh, Aref A. Bin Abdulhak, Haytham Tlayjeh, Mouaz H. Al-Mallah, M. Rizwan Sohail, Leslie C. Hassett, et al. (+2)
73 [GO] 2020―Dec―25 COVID-19 and Renin Angiotensin Aldosterone System: A Pharmacogenomic View Ehab S. EL Desoky
74 [GO] 2020―Dec―25 Anticoagulant Protein S in COVID-19: The Low Activity Level Is Probably Secondary Cristian Baicus, Laura Elena Stoichitoiu, Larisa Pinte, Camelia Badea
75 [GO] 2020―Nov―19 Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients Tarek Kashour, Aref A. Bin Abdulhak, Haytham Tlayjeh, Leslie C. Hassett, Anas Noman, Ala Mohsen, et al. (+2)
76 [GO] 2020―Nov―05 Venous Thromboembolism in Hospitalized COVID-19 Patients Gurusaravanan Kutti Sridharan, Radhakrishna Vegunta, Venkata Ram Pradeep Rokkam, Veeraraghavan Meyyur Aravamudan, Rathnamitreyee Vegunta, Shahab R. Khan, et al. (+5)
77 [GO] 2020―Nov―02 Hydroxychloroquine and COVID-19 Cosima Rughiniş, Lorena Dima, Sorina Vasile
78 [GO] 2020―Oct―06 Tocilizumab-Associated Bowel Perforation in SARS-CoV-2 Infection Purva Ranchal, Evan Yates, Rahul Gupta, Wilbert S. Aronow
79 [GO] 2020―Aug―14 Vitamin D Supplementation in COVID-19 Patients Kim C. Ohaegbulam, Mohamed Swalih, Pranavkumar Patel, Miriam A. Smith, Richard Perrin
80 [GO] 2020―Aug―05 Shedding Light on COVID-19 Brittany Schreiber, Ankit Patel, Ashish Verma
81 [GO] 2020―May―04 Prolonged Viral RNA Shedding Duration in COVID-19 Wei-yun Zhang, Le-qun Yu, Jian-an Huang, Da-Xiong Zeng
82 [GO] 2020―May―04 COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence? Gurusaravanan Kutti Sridharan, Rajesh Kotagiri, Vijay H. Chandiramani, Babu P. Mohan, Rathnamitreyee Vegunta, Radhakrishna Vegunta, Venkata R. P. Rokkam
 [1] 

82 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.009 sec